Lixte Biotechnology News

10-Q: Q3 2024 Earnings Report

SECNov 12 16:54 ET · Announcements

Trending Stocks Today | GlycoMimetics Shoots up 227.4%

Moomoo NewsOct 29 14:00 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaOct 29 08:07 ET

Top Premarket Gainers

MT NewswiresOct 29 07:37 ET

Express News | Shuttle Pharmaceuticals shares surge 81% after it finalized agreements with all six planned site enrollment locations.

Moomoo 24/7Oct 29 06:16 ET

Trending Stocks Today | Lixte Biotechnology Surges 84.73% Pre-Market

Moomoo NewsOct 29 05:00 ET

Lixte Biotechnology Files to Sell Units, No Amount Given

TipRanksOct 23 06:15 ET

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

AccesswireSep 11 13:00 ET

Express News | LIXTE Biotechnology Receives USPTO Notice Of Allowance For Patent On Combining LB-100 With Cancer Immunotherapies, Strengthening Its Intellectual Property Portfolio And Advancing Cancer Treatment Trials

BenzingaSep 4 08:36 ET

Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

BenzingaAug 28 05:23 ET

Express News | Lixte Biotechnology Begins First Patient Dosing In New Clinical Trial With Netherlands Cancer Institute And Roche For Metastatic Colorectal Cancer

BenzingaAug 26 08:31 ET

First Patient Dosed With LIXTE's LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating With NKI, Supported by Major Pharma Company

GlobeNewswireAug 26 08:30 ET

Express News | First Patient Dosed With Lixte’s Lb-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating With Nki, Supported by Major Pharma Company

ReutersAug 26 08:30 ET

LIXTE Biotechnology Provides Update On Recent Activities And Developments; Collaboration With NKI And Funding Support For New Colorectal Cancer Clinical Trial By Major Pharma Co; Preclinical Data Published In Journal EMBO Reports Shows LB-100 As...

BenzingaAug 19 08:42 ET

Lixte Biotechnology Says Jan Schellens Joins Company as Chief Medical Officer >LIXT

Dow JonesAug 19 08:32 ET

Express News | Lixte Biotechnology Provides Update on Recent Activities and Developments

ReutersAug 19 08:30 ET

LIXTE Biotechnology Holdings to Present at Two Investor Conferences

GlobeNewswireAug 15 08:30 ET

Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event

AccesswireAug 14 22:50 ET

10-Q: Q2 2024 Earnings Report

SECAug 8 16:10 ET · Announcements

Express News | Lixte Biotechnology Holdings Inc - Will Provide Its Lead Compound, Lb-100, and Roche Will Provide Atezolizumab for Trial

ReutersJun 14 11:01 ET